Issue 11: Pleiotropy & molecular multitasking: What’s Pharma’s problem? With David Hoffmann - Part II

David Hoffman, FNIMH, AHG

In this issue…

New research

Sambus ebulus as a topical in eczema.

Topic of the day

The pleiotropic advantage of compounds — or the ability of a compound to produce two or more effects — from medicinal plants, and Big Pharma’s reaction.

Interview

A continuation of the interview with David Hoffman. (See Issue 10 for part I.)